Limia Melissa E, Liu Xiu Li, Yu Jennifer, Byrnes Kathleen
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Gastroenterology Res. 2024 Feb;17(1):37-40. doi: 10.14740/gr1687. Epub 2024 Feb 28.
It has been established that more than mild large-droplet macrovesicular steatosis (LD-MAS) is associated with increased risk of graft non-function. In contrast, even severe small-droplet macrovesicular steatosis (SD-MAS) has been found to be less prognostically significant. It remains unclear if a donor liver with diffuse microvesicular steatosis is associated with an increased risk of graft dysfunction. A 56-year-old male with alcoholic cirrhosis was transplanted with a liver from a 42-year-old overweight male donor after brain death. The frozen section of the donor liver biopsy taken at harvest showed diffusely enlarged clear/foamy hepatocytes and mild LD-MAS (about 5-10% of total tissue). The reperfusion liver biopsy taken at time 0 of transplantation showed hemorrhage, pale and enlarged hepatocytes, and mild LD-MAS (about 10% of total tissue) with lipopeliosis. The graft became non-functional, and the patient was re-transplanted 24 h after the initial transplantation. Histologic examination of the failed liver allograft showed extensive hemorrhagic necrosis, neutrophilic inflammation, diffuse microvesicular steatosis, and large extracellular fat droplets (about 20% of total tissue). This case demonstrates that precautions are needed to avoid using livers with diffuse and severe microvesicular steatosis.
已经确定,超过轻度的大滴型大泡性脂肪变性(LD-MAS)与移植肝无功能风险增加相关。相比之下,即使是严重的小滴型大泡性脂肪变性(SD-MAS)在预后方面也被发现意义较小。供肝弥漫性小泡性脂肪变性是否与移植肝功能障碍风险增加相关仍不清楚。一名56岁患有酒精性肝硬化的男性在脑死亡后接受了一名42岁超重男性供体的肝脏移植。获取供肝时所取活检组织的冰冻切片显示肝细胞弥漫性肿大、清亮/泡沫样,且存在轻度LD-MAS(约占组织总量的5%-10%)。移植时0小时所取的再灌注肝活检显示有出血、肝细胞苍白肿大,以及伴有脂质沉着的轻度LD-MAS(约占组织总量的10%)。移植肝无功能,患者在初次移植后24小时接受了再次移植。对失败的移植肝进行组织学检查显示广泛的出血性坏死、中性粒细胞炎症、弥漫性小泡性脂肪变性以及大的细胞外脂肪滴(约占组织总量的20%)。该病例表明,需要采取预防措施以避免使用弥漫性和严重小泡性脂肪变性的肝脏。